Urolithin A for Triathletes

Reviewed by SOMA HEALTH's Medical Research Team

Triathlon is, at heart, a test of mitochondria. Across a swim, a bike leg, and a run, your muscles are asked to turn oxygen and fuel into forward motion for hours at a time. That is exactly the job of the mitochondria inside every muscle cell, which is why the science of mitochondrial quality has become interesting to endurance athletes looking to support how they train and adapt.

Urolithin A (UA) is a compound that has drawn attention in this space. It is not a stimulant and it is not a fuel source. Instead, it works on the housekeeping side of cellular energy: the process of clearing out worn mitochondria so healthier ones can take their place. Below, SOMA HEALTH walks through what is actually known in humans, what is still early, and how a triathlete might think about it honestly.

Why mitochondria matter across swim, bike, and run

Endurance performance is tightly linked to the amount and quality of mitochondria in your working muscles. Structured aerobic training is the single most powerful driver of mitochondrial biogenesis, the creation of new mitochondria, and years of physiology research show that trained endurance athletes carry markedly higher mitochondrial density than untrained people. That density is part of why a seasoned triathlete can hold a strong pace on the bike and still run off it.

But building new mitochondria is only half the story. Cells also need to recycle damaged ones through a quality-control process called mitophagy. When that clean-up slows, worn-out mitochondria accumulate, and the average efficiency of the pool drifts down. Urolithin A is studied specifically because it appears to support mitophagy, which is what makes it conceptually relevant to a sport built on repeated, sustained aerobic effort.

What urolithin A is, and where it comes from

UA is a gut postbiotic. Your body does not get it directly from food. Instead, it is produced when gut bacteria break down ellagitannins, compounds found in pomegranate, walnuts, and some berries. Here is the catch: only some people carry the microbes needed to make meaningful amounts of UA from those foods. Estimates suggest a substantial share of adults convert poorly or not at all, which is one reason direct supplementation has been studied at all, since eating more pomegranate does not guarantee you produce the compound. You can read more in our foods high in urolithin A overview and the broader urolithin A guide.

The human evidence, from most established to newest

Proven in humans: safety and a mitochondrial signature

The first-in-human work, Andreux and colleagues (2019, Nature Metabolism), established that UA was safe and well tolerated in healthy older adults at single doses up to 1,000 mg per day, and that it produced a measurable shift in the expression of mitochondrial genes in muscle. For a triathlete, the practical takeaway is foundational rather than performance-specific: the compound reaches muscle and engages mitochondrial pathways, and the tolerability profile at studied doses was reassuring.

Muscle endurance and strength in controlled trials

Two randomized human trials moved the story toward function. Liu, D'Amico and colleagues (2022, JAMA Network Open) gave UA to older adults over roughly four months and reported improvements in measures of muscle endurance. Singh and colleagues (2022, Cell Reports Medicine) studied middle-aged adults over four months across 500 mg and 1,000 mg arms and reported benefits in muscle strength and aspects of exercise performance. These are the results most directly relevant to endurance sport, though it is worth being clear that the participants were not competitive triathletes, and the endpoints were laboratory measures of strength and endurance rather than race times.

Newer human research

More recent human work has extended the picture. A 2024 randomized trial published in the Journal of the International Society of Sports Nutrition looked at eight weeks of UA in resistance-trained men. A 2025 randomized trial in Nature Aging reported that roughly 28 days of UA supported immune-cell mitochondrial health in midlife adults, a theme sometimes described as inflammaging. And a 2025 trial in distance runners has begun to examine the compound in an endurance-athlete population specifically. These studies are promising and directionally consistent, but they remain individual trials rather than a settled consensus.

Preclinical research, clearly labeled

Much of the original excitement traces to preclinical work. Ryu and colleagues (2016, Nature Medicine) showed that UA induced mitophagy and extended lifespan in the worm C. elegans, and improved muscle function in rodents. Separately, preclinical models of osteoarthritis (D'Amico and colleagues, 2022, Aging Cell) have explored effects on joint and cartilage tissue, an area of obvious interest given the repetitive loading of run training, but this remains animal-model research and cannot be read as a joint treatment. Exploration into skin, gut, brain, and heart is also at an early or preclinical stage. These findings are hypothesis-generating; they are not evidence of benefit in human triathletes.

Honest limitations for the endurance athlete

A systematic review of UA in humans (Ageing Research Reviews, 2024) concluded that the evidence base is still emerging. That framing matters. No trial has shown that UA lowers your Olympic-distance run split or raises your functional threshold power, and you should be skeptical of anyone who claims otherwise. What the human data support is narrower and more mechanistic: tolerability at studied doses, engagement of mitochondrial pathways, and improvements in laboratory measures of muscle strength and endurance in non-athlete populations. UA is a potential supporting input to a training program, not a substitute for the training itself, for sleep, or for fueling. For more on mechanism, see what is mitophagy and our page on mitochondrial health.

A note on health: this guide is about supporting normal cellular energy processes, not treating any medical condition. Urolithin A is not a treatment for fatigue, overtraining, injury, or any diagnosed problem. If you are dealing with persistent tiredness, unexplained performance decline, joint pain, or any health concern, please see your doctor rather than relying on a supplement.

Practical guidance

Human trials have used 500 mg to 1,000 mg per day, with 1,000 mg as the top studied dose. Benefits in those trials appeared over months, not days, so consistency through a training block is more logical than dosing around a single race. UA is best thought of as a background support during heavy aerobic volume rather than a race-day stimulant. Because it is not a stimulant, it does not carry the timing considerations of caffeine. If you want to go deeper on numbers and timing, see best urolithin A gummies.

Shop SOMA HEALTH Urolithin A Gummies

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.